Other languages Lupin Limited

Equities

LUPIN

INE326A01037

Delayed Bombay S.E. Other stock markets 04:35:02 2024-05-06 am EDT			5-day change	1st Jan Change
1,652 ^INR	-0.20%		+0.94%	+24.94%

Apr. 24	Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility	MT
Apr. 22	INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains	RE

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility	Apr. 23
INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains	Apr. 22
Lupin Limited Announces Launch of Mirabegron Extended-Release Tablets, 25 Mg, in the United States, After Having Received an Approval from the United States Food and Drug Administration	Apr. 20
US FDA Clears Lupin's API Plant in Gujarat, India, Following GMP Inspection	Apr. 12
Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US	Apr. 09
Lupin Launches Generic Drug for Inflammatory Lesions of Rosacea in US	Apr. 09
Lupin Limited Announces the Launch of First Generic Version of Oracea® (Doxycycline Capsules, 40 Mg), in the United States	Apr. 09
Indian Equities Close with Marginal Loss on Wednesday as Traders Scale Down Hopes on US Rate Cuts	Apr. 03
Lupin Names Chief Quality Officer	Apr. 03
Lupin Limited Announces Change in Management	Apr. 03
Lupin to Transfer Trade Generics Business to Subsidiary Lupin Life Sciences	Mar. 25
Indian Equities Start Week in Black, Aided by Major Auto and Metal Firms	Mar. 18
Lupin Names Chief Technical Operations Officer	Mar. 18
Lupin Limited Appoints Christoph Funke as Chief Technical Operations Officer	Mar. 18
Boehringer to cut out-of-pocket costs for inhalers to $35	Mar. 07
EXCLUSIVA-Eli Lilly podría lanzar un fármaco contra la obesidad en India el próximo año: presidente ejecutivo	Feb. 28
India pharma companies develop versions of Wegovy to get in on weight-loss windfall	Feb. 22
Lupin Gets US FDA Nod for Minzoya Tablets	Feb. 16
Lupin Limited Receives Approval from U.S. FDA for Minzoyatm	Feb. 16
Lupin Launches Fertility Medicine Ganirelix in US	Feb. 15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Lupin Limited

Equities

LUPIN

INE326A01037

Other languages

Filters